Invest India：2023年印度制药行业分析报告（中译版）（20页）.pdf

1、PHARMACEUTICALSSECTORHIGHLIGHTS23rd largestby volume14th largestby value Highest number of US FDA approvedplants outside the US500+APIs,60,000 generic brands across60 therapeutic categories200+countries served by Indian pharma exports100+Pharmaceutical and Medical Device Clusters#1*supplier of DPT,B

2、CG,and Measles Vaccine#1Supplier of generic drugs,accounting for over 20%of the global generic demand3,000+drug companies and 10,500 manufacturingunitsSupplier of over65%*of WHO demand for DPT&BCG vaccines,and 90%of measles vaccinesSector contributesto 1.72%ofIndias GDPOver 55%Exports toHighly Regul

3、ated Markets*Source:BIRAC3CURRENT SCENARIOMARKET SIZE:Indian Pharmaceuticals Export Market(USD Bn)USD 41.7 Bn(FY 20-21)MARKET GROWTH RATE:10-12%EXPORTS:FDI INFLOWS:USD 19.2 Bn(April 2000 toDecember 2021)MAJOR SEGMENTS:Generic drugs,OTC Medicines and API/Bulk Drugs,Vaccines,Contract Research&Manufact

4、uring,Biosimilars&BiologicsDuring 2020-21,Indias totalpharma export stood at USD 24.4 Bn against the total pharma import of USD 7.0 Bn,thus generating trade surplus of USD 17.5 Bn.10.112.614.514.916.916.817.319.120.624.5Fy12Fy13Fy14Fy15Fy16Fy17Fy18Fy19Fy 20FY 2145FUTURE POTENTIALIndian Pharmaceutica

5、lsmarket is expected to reachUSD 130 Bnby 2030FOCUS STATES:Andhra Pradesh,Goa,Gujarat,Haryana,Himachal Pradesh,Karnataka,Maharashtra,North-East Region,Punjab,Tami Nadu,Telangana,Uttar PradeshNo.of Units*(Excl.wholesale/retail)4,900Formulations1,500APIs30Vaccines800Medical Devices2,300Cosmetics8,650M

6、iscellaneousSegment-wise ExportsRegion-wise Exports(FY 19-20)20172%20%75%2%2%20%74%3%2%20%74%3%2%19%76%3%2%18%77%3%2018201920202021SurgicalsFormulations&BiologicalsBulk Drugs&IntermediatesOthers*15%EU6%Asean6%LAC6%Middle East4%South Asia5%CIS4%Asia(ExclMiddle East)2%Oceania33%North America18%Africa1